{"id":"NCT00451958","sponsor":"Ferring Pharmaceuticals","briefTitle":"A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy","officialTitle":"An Open-Label, Multi-Centre, Extension Study, Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Patients With Prostate Cancer Requiring Androgen Ablation Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03","primaryCompletion":"2011-10","completion":"2011-12","firstPosted":"2007-03-26","resultsPosted":"2013-03-21","lastUpdate":"2013-03-21"},"enrollment":386,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Prostate Cancer"],"interventions":[{"type":"DRUG","name":"Degarelix 80 mg / Degarelix 80 mg","otherNames":["Firmagon"]},{"type":"DRUG","name":"Degarelix 160 mg / Degarelix 160 mg","otherNames":["Firmagon"]},{"type":"DRUG","name":"Leuprolide 7.5 mg / Degarelix 80 mg","otherNames":["Firmagon","Lupron"]},{"type":"DRUG","name":"Leuprolide 7.5 mg / Degarelix 160 mg","otherNames":["Firmagon","Lupron"]}],"arms":[{"label":"Degarelix 80 mg / Degarelix 80 mg","type":"EXPERIMENTAL"},{"label":"Degarelix 160 mg / Degarelix 160 mg","type":"EXPERIMENTAL"},{"label":"Leuprolide 7.5 mg / Degarelix 80 mg","type":"EXPERIMENTAL"},{"label":"Leuprolide 7.5 mg / Degarelix 160 mg","type":"EXPERIMENTAL"}],"summary":"Participants who completed the FE200486 CS21 study (NCT00295750) could enter the FE200486 CS21A study. The study continued until all non-discontinued participants had received treatment for at least 5 years.","primaryOutcome":{"measure":"Number of Participants With Markedly Abnormal Values in Vital Signs and Body Weight","timeFrame":"Up to 4 years of treatment","effectByArm":[{"arm":"Degarelix 80 mg / Degarelix 80 mg","deltaMin":3,"sd":null},{"arm":"Degarelix 160 mg / Degarelix 160 mg","deltaMin":6,"sd":null},{"arm":"Leuprolide 7.5 mg / Degarelix 80 mg","deltaMin":3,"sd":null},{"arm":"Leuprolide 7.5 mg / Degarelix 160 mg","deltaMin":6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":3},"locations":{"siteCount":69,"countries":["United States","Canada","Czechia","Germany","Hungary","Mexico","Netherlands","Puerto Rico","Romania","Russia","Ukraine","United Kingdom"]},"refs":{"pmids":["34350976"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":43,"n":207},"commonTop":["Injection site pain","Hot flush","Injection site erythema","Weight increased","Weight decreased"]}}